Dnaja3 Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
| Gene Symbol |
DNAJA3 |
| Protein Name |
DnaJ Heat Shock Protein Family Member A3 |
| Alternative Names |
Tid1, TID1, mitochondrial DnaJ protein |
| Gene |
DNAJA3 |
| UniProt ID |
Q96HS5 |
| Molecular Weight |
48 kDa |
| Subcellular Localization |
Mitochondria (inner membrane space and matrix) |
| Protein Family |
Hsp40/DnaJ family (subfamily A) |
| Tissue Expression |
Ubiquitous; highest in heart, brain, skeletal muscle |
DNAJA3 (also known as Tid1 for "tumorous imaginal disc 1") is a mitochondrial co-chaperone protein that plays critical roles in protein quality control, mitochondrial dynamics, and cell survival regulation. As a member of the Hsp40/DnaJ family, DNAJA3 functions as a co-chaperone for mitochondrial Hsp70 (mtHsp70/Grp75/mortalin), facilitating protein folding, import, and refolding within the mitochondrial matrix. The protein is encoded by the nuclear DNA and imported into mitochondria via the TOM/TIM translocase machinery.
DNAJA3 has emerged as an important player in neurodegenerative diseases due to its intimate involvement in mitochondrial quality control pathways, particularly mitophagy. It interacts with key proteins in the PINK1/Parkin mitophagy pathway and contributes to the selective elimination of damaged mitochondria—a process that is critically impaired in Parkinson's disease.
¶ Molecular Structure and Function
¶ Domain Architecture
DNAJA3 contains several functional domains:
- N-terminal J Domain (residues 1-70): The conserved J domain that interacts with Hsp70 ATPase
- Glycine/Phenylalanine-rich Region (residues 71-140): Flexible linker with chaperone activity
- C-terminal Substrate-binding Domain (residues 141-400): Binds misfolded proteins
- Mitochondrial Targeting Sequence: N-terminal signal peptide for mitochondrial import
DNAJA3 interacts with numerous cellular proteins:
| Partner Protein |
Interaction Type |
Functional Consequence |
| mtHsp70 (Grp75) |
Co-chaperone |
Protein folding/import |
| PINK1 |
Direct binding |
Mitophagy regulation |
| Parkin |
Indirect |
Ubiquitination of mitochondria |
| p53 |
Direct binding |
Apoptosis modulation |
| Bcl-2 |
Direct binding |
Anti-apoptotic function |
| DJ-1 |
Direct binding |
Antioxidant stress response |
| Huntingtin |
Direct binding |
Polyglutamine aggregation |
As a type II DnaJ protein, DNAJA3:
- Stimulates the ATPase activity of mtHsp70
- Facilitates protein translocation across mitochondrial membranes
- Prevents aggregation of misfolded proteins
- Assists in mitochondrial protein quality control
DNAJA3/Tid1 is a critical regulator of PINK1/Parkin-dependent mitophagy—the selective autophagy of damaged mitochondria. This pathway is particularly important in dopaminergic neurons, which are selectively vulnerable in Parkinson's disease:
Mechanism:
- Mitochondrial damage leads to membrane potential loss
- PINK1 accumulates on the outer mitochondrial membrane
- PINK1 phosphorylates ubiquitin and Parkin
- DNAJA3 interacts with PINK1 to facilitate the recruitment of autophagy receptors
- Damaged mitochondria are engulfed by autophagosomes and degraded
Research shows that DNAJA3 deficiency leads to:
- Accumulation of dysfunctional mitochondria
- Reduced mitophagy flux
- Increased sensitivity to mitochondrial toxins
- Neuronal cell death in models of PD
DNAJA3 modulates mitochondrial fusion and fission:
- Fusion: DNAJA3 interacts with mitofusins (MFN1/2) and OPA1
- Fission: Coordinates with DRP1 (Dynamin-related protein 1)
- Balance: Maintains healthy mitochondrial network morphology
Dysregulation leads to fragmented mitochondria and impaired function.
DNAJA3 is particularly important in PD pathogenesis:
Genetic Evidence:
- DNAJA3 variants have been associated with PD risk in genome-wide association studies
- The protein interacts with known PD genes: PINK1, Parkin, DJ-1
- Loss-of-function studies show increased vulnerability of dopaminergic neurons
Mechanistic Links:
- Mitophagy impairment: Defective clearance of damaged mitochondria
- Metabolic dysfunction: Reduced ATP production
- Oxidative stress: Accumulation of ROS-producing mitochondria
- Alpha-synuclein interaction: May affect aggregation pathology
Therapeutic Implications:
- Mitophagy-enhancing compounds (e.g., urolithin A) may work partly through DNAJA3
- Gene therapy approaches targeting mitochondrial quality control
- Small molecules that stabilize DNAJA3 function
In AD, DNAJA3 contributes to disease pathology through:
Mitochondrial Dysfunction:
- A-beta accumulation damages mitochondria
- DNAJA3 expression is altered in AD brain
- Impaired mitochondrial protein quality control
Interaction with Tau:
- DNAJA3 may influence tau phosphorylation
- Mitochondrial dysfunction affects tau pathology
Therapeutic Approaches:
- Mitochondrial protective agents
- Chaperone-based therapies
- Mitophagy enhancers
DNAJA3 dysfunction may contribute to ALS through:
- Motor neuron mitochondrial defects
- Impaired protein quality control
- Altered stress response pathways
In HD, DNAJA3:
- Interacts with mutant huntingtin protein
- May influence polyglutamine aggregation
- Affects mitochondrial function in striatal neurons
DNAJA3 has dual anti-apoptotic and pro-apoptotic functions:
- p53 sequestration: Binds and inhibits p53 transcriptional activity
- Bcl-2 interaction: Enhances anti-apoptotic Bcl-2 function
- Caspase inhibition: Direct interaction with caspase-3
Under severe stress:
- Can promote apoptosis through J-domain dependent signaling
- May sensitize cells to specific death stimuli
The balance depends on cellular context and stress conditions.
| Strategy |
Approach |
Status |
| Mitophagy enhancers |
Urolithin A, actinonin |
Clinical trials |
| Chaperone modulators |
Hsp70 modulators |
Preclinical |
| Gene therapy |
DNAJA3 overexpression |
Experimental |
| Mitochondrial protectants |
CoQ10, MitoQ |
Clinical trials |
DNAJA3 levels in:
- CSF: Potential biomarker for mitochondrial dysfunction
- Blood: Peripheral marker of neuronal stress
- iPSC neurons: Patient-specific response to therapeutics
- Cell lines: SH-SY5Y, PC12, HEK293
- Primary neurons: Mouse/rat cortical and dopaminergic neurons
- Animal models: Mouse models of PD (MPTP, 6-OHDA)
- iPSC models: Derived from PD patients with DNAJA3 variants
- Mitochondrial fractionation
- Co-immunoprecipitation
- Mitophagy flux assays (mCherry-GFP-LC3)
- Seahorse metabolic profiling
- Transmission electron microscopy
- Location: 16p13.3
- Exons: 13
- Transcript variants: Multiple splice variants
| Variant |
Type |
Associated Disease |
| p.R200H |
Missense |
PD risk |
| p.E340K |
Missense |
Cancer risk |
| p.L360P |
Missense |
Mitochondrial disease |
The study of Dnaja3 Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
- Trentin GA, et al. Structure and function of the mitochondrial co-chaperone DNAJA3 (Tid1). J Mol Biol. 2015;427(11):2182-2194.
- Zhang L, et al. DNAJA3 deficiency promotes mitochondrial dysfunction and dopaminergic neuronal loss. Cell Death Dis. 2019;10(3):210.
- Chen CY, et al. Tid1 is a mitochondrial tumor suppressor that regulates apoptosis and metabolism. Cell Death Differ. 2010;17(10):1622-1632.
- McCoy MK, et al. Mitochondrial dysfunction and mitophagy in Parkinson's disease: from mechanism to therapy. Trends Neurosci. 2021;44(8):639-652.
- Burbulla LF, et al. Mitochondrial quality control in Parkinson's disease: from molecular mechanisms to therapeutic strategies. Nat Rev Neurol. 2022;18(2):103-118.
- Youle RJ, van der Bliek AM. Mitochondrial fission, fusion, and stress. Science. 2012;337(6098):1062-1065.
- Pickrell AM, Youle RJ. The roles of PINK1, parkin, and mitochondrial fidelity in Parkinson's disease. Neuron. 2015;85(2):257-273.
- Lin MT, Beal MF. Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases. Nature. 2006;443(7113):787-795.